Evidence map›Paper›PMID 19095997›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2009

Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.

Marcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, Brian W C Wong, Nagat Bissada, Piers Ruddle, Anatol Kontush, Hala Hussein, Mahmoud A Pouladi, M John Chapman and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of Stearoyl-CoA Desaturase 1 in Cardiovascular Physiology.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Monounsaturated Fatty Acids in Obesity-Related Inflammation.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Marcia L E MacDonaldCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, and Child & Family Research Institute, 980 West 28th Avenue, Vancouver, BC, Canada V5Z 4H4.
Miranda van Eck
Reeni B Hildebrand
Brian W C Wong
Nagat Bissada
Piers Ruddle
Anatol Kontush
Hala Hussein
Mahmoud A Pouladi
M John Chapman
Catherine Fievet
Theo J C van Berkel
Bart Staels
Bruce M McManus
Michael R Hayden
St. Paul's Hospital · CALeiden University · NL

Funding

CIHR 68411
6 · The paper itself

Abstract

objectiveAbsence of stearoyl-CoA desaturase-1 (SCD1) in mice reduces plasma triglycerides and provides protection from obesity and insulin resistance, which would be predicted to be associated with reduced susceptibility to atherosclerosis. The aim of this study was to determine the effect of SCD1 deficiency on atherosclerosis. METHODS AND

resultsDespite an antiatherogenic metabolic profile, SCD1 deficiency increases atherosclerosis in hyperlipidemic low-density lipoprotein receptor (LDLR)-deficient mice challenged with a Western diet. Lesion area at the aortic root is significantly increased in males and females in two models of SCD1 deficiency. Inflammatory changes are evident in the skin of these mice, including increased intercellular adhesion molecule (ICAM)-1 and ulcerative dermatitis. Increases in ICAM-1 and interleukin-6 are also evident in plasma of SCD1-deficient mice. HDL particles demonstrate changes associated with inflammation, including decreased plasma apoA-II and apoA-I and paraoxonase-1 and increased plasma serum amyloid A. Lipopolysaccharide-induced inflammatory response and cholesterol efflux are not altered in SCD1-deficient macrophages. In addition, when SCD1 deficiency is limited to bone marrow-derived cells, lesion size is not altered in LDLR-deficient mice.

conclusionsThese studies reinforce the crucial role of chronic inflammation in promoting atherosclerosis, even in the presence of antiatherogenic biochemical and metabolic characteristics.

Indexed as

AnimalsApolipoproteinsAryldialkylphosphataseAtherosclerosisDisease Models, AnimalDisease ProgressionFemaleHyperlipidemiasInflammationInflammation MediatorsIntercellular Adhesion Molecule-1Interleukin-6Lipoproteins, HDLMacrophagesMaleMiceApolipoproteinsAryldialkylphosphataseInflammation MediatorsIntercellular Adhesion Molecule-1Interleukin-6Lipoproteins, HDLReceptors, LDLScd1 protein, mouseSerum Amyloid A ProteinStearoyl-CoA Desaturase

Identifiers

PMID19095997
PMCPMC2873333
OpenAlexW2169294908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.